Soleno: Blockbuster Launch In Progress

See more on the latest on Soleno Therapeutics (SLNO) stock after VYKAT XR approval. Learn why post-approval commercialization ...
Local 12 WKRC Cincinnati

NKY student with Prader-Willi syndrome fulfills dream of playing for basketball team

BOONE COUNTY, Ky. (WKRC) - It was a dream come true for a senior at Ryle High School who loves sports. Jacob Arnold is usually the team manager for the Raiders basketball team, but he got the nod to ...

Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome

Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for ...
The Globe and Mail

Prader-Willi Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno ...

The Key Prader-Willi Syndrome Companies in the market include - Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, Aardvark ...

Soleno rated as new Buy at Goldman Sachs on Vykat XR potential

Soleno Therapeutics (SLNO) has been initiated with Buy at Goldman Sachs citing strong fundamentals and blockbuster potential ...

Acadia slumps after trial setback for Prader-Willi syndrome drug; Soleno jumps

Acadia Pharma (NASDAQ:ACAD) shares fell in the premarket on Wednesday after the biotech announced that its experimental therapy for a rare genetic condition known as Prader-Willi syndrome failed in a ...
Healio

CARE-PWS: Intranasal oxytocin analogue reduces hyperphagia in Prader-Willi syndrome

Please provide your email address to receive an email when new articles are posted on . Adults with Prader-Willi syndrome who received an intranasal oxytocin analogue for 8 weeks reported a ...
MedCity News

Prader-Willi syndrome

Soleno Therapeutics’ Vykat XR is now FDA approved for treating hyperphagia, or excessive hunger, in patients with Prader-Willi syndrome. The once-daily pill is the first approved therapy for this rare ...
Business Wire

Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (intranasal carbetocin) for Prader-Willi Syndrome

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the addition of a new Phase 3 development candidate to its rare disease portfolio, ACP-101 (intranasal carbetocin ...
Healio

FDA grants orphan drug designation for Prader-Willi syndrome treatment

The FDA granted orphan drug designation to an investigational drug for the treatment of Prader-Willi syndrome, according to an industry press release. Tesomet (Saniona) is an investigational, ...
Mena FN

Prader-Willi Syndrome Market To Experience Notable Growth In Forecast Span By 2034, Delveinsight Predicts Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics ...

(MENAFN- GetNews) The Key Prader-Willi Syndrome Companies in the market include - Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, ...